Multi-Center Assessment of Infiltration Rates in FDG-PET/CT scans: Detection, Incidence, and Contributing Factors

被引：0
|
作者：
Townsend, David [1 ]
Benefield, Thad [4 ]
Perrin, Steven [3 ]
Ryan, Kelley [3 ]
Lattanze, Ronald [3 ]
Wong, Terence [2 ,4 ]
机构：
[1] ASTAR, NUS Clin Imaging Res Ctr, Singapore, Singapore
[2] Duke Univ, Durham, NC USA
[3] Lucerno Dynam LLC, Cary, NC USA
[4] Univ N Carolina, Chapel Hill, NC 27515 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
520
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Clinical value of whole body 18F-FDG PET/CT imaging in patients with cutaneous melanoma: A multi-center cohort study
    Bower, Nichole
    Morris, Amy
    O'Connor, Janet
    Sponagle, Melissa
    Bahr, Rebekah
    Gilbert, Robert
    Mohamed, Abdolell
    Bower, Jonathan
    JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2024, 55 (02) : 212 - 220
  • [32] High incidence of progression of non-small cell lung cancer between staging and treatment-planning FDG-PET/CT scans in candidates for radical radiation therapy
    MacManus, M.
    Bayne, M.
    Everitt, S.
    Ball, D.
    Hicks, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S463 - S463
  • [33] Identification of factors contributing to misdiagnosis in assessment of lymph node metastases among patients with NSCLC imaged by 18F-FDG PET/CT
    Teodorczyk, J.
    Brockhuis, B.
    Romanowicz, G.
    Cytawa, W.
    Wenzel-Duszynska, I.
    Kozlowska-Gladki, J.
    Lass, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S309 - S309
  • [34] Comparison of progressive ComBat for harmonization of radiomics features in multi-center head and neck tumor FDG PET/CT dataset from HECKTOR Challenge 2021
    Xu, Hui
    Lu, Lijun
    Hatt, Mathieu
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [35] Optimizing Low-Dose [18F]FDG-PET/CT Scans: Ensuring Quality Amid Radiotracer Availability Challenges - Insights from a Peripheral Tertiary Care Center
    Tayal, Sachin
    Jain, Yash
    Thakur, Sonali
    Shukla, Varun
    Venkatachalam, Manikandan Marappagounder
    Kumar, Ajay
    Sinha, Ritwik
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2024, 39 (04): : 292 - 298
  • [36] Head motion evaluation and correction for PET scans with 18F-FDG in the Japanese Alzheimer’s disease neuroimaging initiative (J-ADNI) multi-center study
    Yasuhiko Ikari
    Tomoyuki Nishio
    Yoko Makishi
    Yukari Miya
    Kengo Ito
    Robert A. Koeppe
    Michio Senda
    Annals of Nuclear Medicine, 2012, 26 : 535 - 544
  • [37] Head motion evaluation and correction for PET scans with 18F-FDG in the Japanese Alzheimer's disease neuroimaging initiative (J-ADNI) multi-center study
    Ikari, Yasuhiko
    Nishio, Tomoyuki
    Makishi, Yoko
    Miya, Yukari
    Ito, Kengo
    Koeppe, Robert A.
    Senda, Michio
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (07) : 535 - 544
  • [38] Head motion evaluation and correction for PET scans with 18F-FDG in the Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI) multi-center study
    Ikari, Yasuhiko
    Nishio, Tomoyuki
    Makishi, Yoko
    Miya, Yukari
    Senda, Michio
    Ito, Kengo
    Koeppe, Robert
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [39] A multi-center European study to explore the detection of oligometastatic disease by PSMA-PET/CT in intermediate to high-risk Prostate Cancer
    Zuccotti, G.
    Mattana, F.
    Barone, A.
    Muraglia, L.
    Mei, R.
    Farolfi, A.
    Rajwa, P.
    Miszczyk, M.
    Kasivisvanathan, V.
    Zattoni, F.
    Gandaglia, G.
    Briganti, A.
    Shariat, S.
    Castellucci, P.
    Fanti, S.
    Ceci, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S175 - S176
  • [40] 18F-FDG PET/CT-based habitat radiomics combining stacking ensemble learning for predicting prognosis in hepatocellular carcinoma: a multi-center study
    Sui, Chunxiao
    Su, Qian
    Chen, Kun
    Tan, Rui
    Wang, Ziyang
    Liu, Zifan
    Xu, Wengui
    Li, Xiaofeng
    BMC CANCER, 2024, 24 (01)
12345